We have previously reported the isolation of a retrovirus (HTLV for human T-cell leukemia-lymphoma virus) from a patient with cutaneous T-cell lymphoma 131. HTLV was shown to be unrelated to previously described retroviruses and not endogenous to humans, and integrated proviral DNA was present and expressed into mRNA in the malignant T cells of the Same patient [5] . A closely related virus was subsequently isolated from a patient with cutaneous T-cell leukemia-lymphoma [4] . Since then we (Popovic et al., in preparation; Gallo et al. and Sarin et al., this volume) and others [2] have also isolated virus from a number of other patients. All appear quite closely related to the first HTLV isolate (Popovic et al., submitted; Gallo et al., this volume).
Subsequent to the discovery of HTLV in two separate T-cell lines from the first patient (CR), we became aware of the exis- and CR-B, a B-cell line derived from peripheral blood after immortalization with Epstein-Barr virus strain B-95. The presence of HTLV was assayed in at least one of several ways: (1) p19 was assayed by indirect immunofluorescence using a murine monoclonal antibody; (2) p24 was assayed with a RIP assay using goat hyperimmune Sera (see Sarngadharan et al., this volume); (3) RNA and (4) DNA were assayed by liquid hybridization as described by Reitz et al. [5] .
HTLV was abundantly present in the HUT-102 line and the derived clones B2 and A9 (Table 1) . The great majority (-90%) of these cells expressed p19, and provirus was present at three to four copies per haploid genome. CTCL-3 also contained HTLV, since 15%-20% of these cells CTC-16 also contains HTLV-infected cells since 35%-40% of the cells express p19. C6 and G5, derived from CTC-16, are negative for both p19 and proviral DNA (to a Cot of 20,000). Low levels of p24 are detectable (-1% of that observed with B2 and Ag). Our interpretation of this data is that C6 and G5 are not clonal with respect to HTLV provirus and that only a few cells are infected and producing protein. Since the p24 assay is more sensitive than the p19 assay under the conditions used, low levels of pl9 expression could give a negative result.
All the cell lines were analyzed for surface markers with a FACS I1 cell sorter. The cells within the cultures with high levels of HTLV tended to be OKT 4' 3-6-8-10- (Table 1) . C6, which contained mostly uni'nfected cells, was predominantly OKT 3' 4-6-8-10-, and G5 (also mostly containing uninfected cells) was largely OKT 8' 3-4-. Thus, in patient CT, HTLV appears to be mostly present in the peripheral blood in a particular Set of T cells.
All the cell lines used were typed for HLA expression in order to verify that they originated from CR. All had the Same HLA-DR haplotype as the patient and all expressed HLA-Aw30 and Aw31 antl HLA-B17 and -B18, consistent with the haplotype of fresh cells from CR and with that of his parents (Table 2) . However, all the infected T-cell lines expressed extra, inappropriate HLA determinants on all of the cells, as judged by microcytotoxicity assays. This has now been observed with infected T cells from six different patients and with cord blood T cells infected with HTLV in vitro. DNA was purified from T and B cells, and digested with different restriction enzymes. We then hybridized these DNA digests to labeled HLA cloned DNA [6] , by the Southern blot technique. Most restriction patterns for the two DNAs were similar, indicating that there are no massive rearrangements of the HLA gene complex. However, the patterns differed after digestion with HpaII and XhoI. Since these enzymes are inhibited by DNA methylation, this suggests that the band T cells differ with respect to the degree of methylation of their HLA class I genes. Whether this is due to virus infection is a question of obvious interest. The exact nature of these possible methylation differences, as well as of the proteins which
